Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern.
Akache B, Renner TM, Stuible M, Rohani N, Cepero-Donates Y, Deschatelets L, Dudani R, Harrison BA, Gervais C, Hill JJ, Hemraz UD, Lam E, Régnier S, Lenferink AEG, Durocher Y, McCluskie MJ.
Akache B, et al.
NPJ Vaccines. 2022 Oct 12;7(1):118. doi: 10.1038/s41541-022-00540-7.
NPJ Vaccines. 2022.
PMID: 36224247
Free PMC article.